Market Tracker

09/30 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

33.88
Data as of Sep 30
 -1.81 / -5.07%
Today’s Change
27.51
Today|||52-Week Range
39.95
+16.03%
Year-to-Date

Today’s Trading

Previous close35.69
Today’s open35.75
Day’s range33.52 - 35.79
Volume1,040,960
Average volume (3 months)656,165
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-45.73%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio75.3
Price/Sales3.49
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-0.96-4.12%
AUXLAuxilium Pharmaceuti...-0.59-1.94%
PTCTPTC Therapeutics Inc-1.61-3.53%
LCILannett Company Inc+0.26+0.57%
Data as of 4:14pm ET, 09/30/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts